Clinical Trial Update: Tadalafil as Adjuvant Therapy for DMD [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update indicating tadalafil is being studied as adjuvant therapy for Duchenne Muscular Dystrophy in Phase 2/3 trials, with active but not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• TADALAFIL (TADALAFIL)

Snippet

Sponsor: University of Florida | Conditions: Duchenne Muscular Dystrophy | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING